Skip to main content

Brian A. Ratner

Brian Ratner is a Partner at Hausfeld and Head of the firm’s International practice. He also serves on the firm’s Management Committee and leads the firm’s global business development efforts. Brian has extensive experience representing U.S. and international businesses in complex litigation at the trial and appellate levels. He is particularly experienced in litigating and resolving antitrust claims in U.S. and European courts, recovering over $100 million for his corporate clients in the last year alone.

Brian’s broad experience demonstrates his ability to tackle and find solutions for the most novel legal issues, as well as represent his clients at all stages of global antitrust litigation, whether in the discovery, damages, trial, appeal or settlement phase, or whether in the U.S., Europe, or globally. This unique combination enables him to counsel and act for clients comprehensively, in a commercially sensitive manner, and wherever necessary.

Plus Moins

Domaines de pratique

Antitrust / Competition

  • In re Rail Freight Fuel Surcharge Antitrust Litigation – Brian represents large corporations that directly purchased rail freight shipping services from BNSF, CSX, Norfolk Southern, and Union Pacific in their claims for damages stemming from the alleged rail freight cartel in the early 2000s.
  • In re Vitamins Antitrust Litigation – Brian served as co-lead counsel in the landmark case on behalf of vitamin direct purchasers who were overcharged as a result of a ten-year global price-fixing and market allocation conspiracy. The case settled for over $1 billion, and in 2003 the case went to a jury trial resulting in a verdict of $148 million in trebled damages. The jury trial was the twelfth largest U.S. jury verdict that year.
  • Empagran, S.A. et al. v. F. Hoffmann-LaRoche, Ltd., et al. – Brian was one of the principal lawyers that led this case on behalf of foreign vitamin purchasers. The case was litigated all the way to the Supreme Court, resulting in a groundbreaking judgment on the scope of the U.S. Sherman Act jurisdiction. The case was designated as the “Matter of the Year” by The Global Competition Review.
  • In re Vitamin C Antitrust Litigation – Brian serves as co-lead counsel in this landmark case alleging a conspiracy to fix the price and limit the supply of Vitamin C sold for export to the United States. The case resulted in entry of a 2013 judgement for $153.3 million post jury verdict in the director purchasers’ favor – the thirteenth largest U.S. verdict in 2013. To date, settlements total $32.5 million. The jury verdict was appealed to the U.S. Supreme Court which ruled unanimously in 2018 in favor of the class and set the standard of deference to be afforded a foreign government’s submissions in U.S. courts. In 2018, the case was awarded The Global Competition Review’s “Litigation of the Year – Cartel Prosecution” award in 2018, as well as the American Antitrust Institute’s “Outstanding Antitrust Litigation Achievement in Private Law Practice” honor.
  • Oncology & Radiation Associates v. Bristol-Myers Squibb Co. – Brian served as one of the lead lawyers in a case of unlawful monopolization against a drug manufacturer, which settled for $65 million.
  • Molecular Diagnostics Laboratories v. Hoffmann-La Roche, Inc., et al. – Brian served as co-lead counsel in a case alleging unlawful monopolization on behalf of purchasers of an enzyme used in DNA amplification, human-genome research, and medical diagnostics, which settled for $33 million.
  • In re American Express Anti-Steering Rules Antitrust Litigation – Brian serves as one of the lead lawyers representing the class.
  • Brian has been representing car manufacturers and other OEMS including BMW, PSA and GKN regarding their auto parts cartel damage claims, and helping them achieve outstanding recoveries.
  • Brian acted on the defense side on behalf of Geodis in a U.S. class action against freight forwarders alleging a conspiracy to fix surcharges on air cargo shipments.

Antitrust Counseling and Compliance

  • Brian advises businesses on the antitrust implications of their business practices and supply relationships, and works with them to craft approaches to both eliminate or reduce potential risk as well as protect and enhance their ability to pursue antitrust claims.

Financial Services and Securities

  • MTB Investment Partners, LP v. Siemens Hearing Instruments, Inc. – Brian served as one of the lead counsel in this securities fraud matter that led to a settlement that returned more than 115% of recognized losses after attorneys’ fees and expenses to former shareholders in HearUSA, Inc.

Ce que les autres en dissent

  • For the past 6 years, The Legal 500, which provides comprehensive worldwide coverage on legal services and rankings, selected Brian as one of the “Leading Lawyers” in the U.S. representing plaintiffs in antitrust matters, stating that: [T]he ‘incredibly impressive . . . Brian Ratner [is a] highly skilled negotiator and litigator, and real fighter with an outstanding strategic sense . . . brilliant lawyer Brian Ratner is a very smart and business-oriented negotiator . . . [He] thinks strategically, is an excellent negotiator and has a solid foundation of substantive law.” In 2011, the publication also recommended him as an “engaging, highly competent professional who can simplify complex antitrust matters and make them comprehensible to a non-antitrust attorney.”
  • Brian has been selected to the Washington, DC Super Lawyers list year after year (2014-Present)
  • Brian was named to the prestigious Lawdragon list of the top 500 “Leading Lawyers in America” (2018-Present) and to the Lawdragon list of "Leading Plaintiff Financial Lawyers" (2019)
  • The American Antitrust Institute honored Brian, as part of the Vitamin C case team, with the award for “Outstanding Antitrust Litigation Achievement in Private Law Practice” (2018). Soon after, the Global Competition Review honored the team with the award for “Litigation of the Year – Cartel Prosecution” (2019).
  • Who’s Who Legal named Brian as a top attorney in the Competition: Plaintiff category (2018-Present), stating that: “Brian Ratner has ‘a brilliant legal mind while being extremely pragmatic and commercially minded’, comment interviewees. He is praised as a lawyer who ‘goes the extra mile’, and whose ‘high-quality work product is feared by competitors.’”
  • The Benchmark Litigation Plaintiff Guide to America’s Leading Plaintiff’s Firms and Attorneys named Brian as one of the country’s top “Antitrust Litigation Stars” (2013), and as one of Washington, DC’s “Local Litigation Stars” (2013-15)
  • Brian was honored by Law360 as one of its “Rising Stars” (2012) and was previously named to the Legal Times’ “40 under 40” list (2009), which recognized rising legal stars expected to play a key role in the Greater Washington legal community for years to come.

Disclaimer: The DC Super Lawyers list is issued by Thomson Reuters; the Legal 500 is published by Legalease Ltd. The Benchmark Plaintiff Guide is published by Euromoney Institutional Investor PLC and Institutional Investor, Inc. The Law360 Rising Stars list is issued by Portfolio Media, Inc. The Legal Times “40 under 40” list is issued by American Lawyer Media. No aspect of this advertisement has been approved by the Supreme Court of New Jersey.


Indiana University- Bloomington, B.A.J., 1996

University of Pittsburgh School of Law, J.D., 1999

Qualification à l’avocature


New Jersey

District of Columbia

Cour suprême des États-Unis

Plusieurs cours fédérales


Managing Editor, Journal of Law and Commerce

Nouveautés et presse

"Jury Finds Chinese Vitamin C Makers Fixed Prices; $153.3M Judgment Entered," Mealey's Legal News & Litigation Reports, March 14, 2013

Hausfeld LLP Named as Tier 1 Firm Nationwide in Plaintiff Antitrust Litigation by The Legal 500, June 2012

"Hausfeld, Hausfeld, Hooray," Legal Bisnow, April 6, 2012

"Brian Ratner, People on the Move,"  Washington Business Journal, April 4, 2012

Rising Star: Hausfeld's Brian Ratner, Law360, March 22, 2012

"U.S. Class Action Lawyers Look Abroad," Reuters, March 20, 2012

"Chinese Cos. Can't Shake Vitamin C Antitrust MDL", Law360, September 7, 2011

Analysis: Private antitrust lawsuits on the decline in U.S.”, Reuters, June 13, 2011

"Plaintiffs' antitrust bar," Global Competition Review, June 30, 2014

Hausfeld LLP Announces Distribution of Settlement Funds in TAQ Antitrust Case, November 19, 2009

Vitamins cartel action filed against Roche in Panama,” Law360, September 11, 2009

2009 Legal Times “40 under 40” list recognizing rising legal stars in Washington, July 14, 2009

Private settlements could gain steam, lawyers say,” Law360, March 12, 2009

Unprecedented Global Settlement Reached with Parker ITR in Marine Hose Cartel,” Class Action Litigation, March 13, 2009

Hausfeld LLP announces first-ever private settlement of global cartel, March 6, 2009

“‘Shell Model’ Opens Door to European Class Actions,” The American Lawyer, January 7, 2008

Hausfeld LLP Named as Tier 1 Firm Nationwide in Mass Tort and Class Action: Plaintiff Representation - Antitrust by The Legal 500, July 2014

Hausfeld LLP Named as one of the top three U.S. firms in Antitrust Plaintiff Representation by The Legal 500, July 2013

"Bar hopping," Global Competition Review, June 30, 2014

Super Lawyers Recognizes Six Hausfeld AttorneysSuper Lawyers, April 25, 2014

Super Lawyers Recognizes Thirteen Hausfeld AttorneysSuper Lawyers, April 17, 2015.

The Legal 500 Names Hausfeld to Top Tier of Firms in Antitrust for Seventh Year, The Legal 500, July 7, 2016. 

"Chambers & Partners, The Legal 500, and Global Competition Review Laud Hausfeld in Competition Law,The Legal 500, June 8, 2017

"What It Takes to Dominate in the Elite Game of International Litigation" The American Lawyer, September 28, 2017


Co-auteurs, Michael Hausfeld et Brian Ratner, "Prosecuting Class Actions and Group Litigation - Understanding the Rise of International Class and Collective Action Litigation and How this Leads to Classes that Span International Borders," World Class Actions, Chapitre 26, septembre 2012

Co-auteur, "Principles and Objectives of Formal and Informal Settlements in EU Competition Cases: The Claimant’s Perspective," document soumis pour le 13ème Atelier en Politique et Droit concurrentiel de l’Institut universitaire européen, publication disponible prochainement

Co-auteur, “A Proposal for a Transitional Forum,” soumis lors de la conférence des réclamations d’anti-monopole à l’encontre des firmes et des cartels étrangers (Law Seminars International), 7-8 septembre 2006

Co-auteur,chapitre 39: USA, The International Comparative Legal Guide to Cartels & Leniency, 2014

Co-auteur, Brian A. Ratner et Sathya S. Gosselin, The Novelty of Wal-Mart v. Dukes, American Bar Association, Business Torts & Civil RICO Committee, Business Torts & RICO News, Vol. 8, numéro 1, Printemps 2011

Présentations et discours

Intervenant de panel, "Private Enforcement: New International Approaches and Developments," Northwestern Law, (May 20, 2015) 

Leader de panel, “Delivering Substantial Shareholder Returns Through Cartel Damages Litigation, on a Risk-Free Basis and with No Financial Investment,” 10th Corporate Counsel & Corporate Compliance Exchange, (April 7-9, 2014) 

Intervenant de panel, "Global antitrust litigatiion - A brave new world," GCR Live 5th Annual Antitrust Law Leaders Forum, (February 5-6, 2016) 

Intervenant de panel, "International- Private Antitrust Enforecment Around the Globe," AAI 11th Annual Private Antitrust Enforcement Conference (November 7, 2017)

Nouvelles et articles de presse assocIés